Register Login

IMMUNEERING CORP (IMRX)

SymbolIMRX
NameIMMUNEERING CORP
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA 02142
Telephone617-500-8080
Fax—
Email—
Websitehttps://www.immuneering.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001790340
Description

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The companys proprietary computational Disease Cancelling Technology platform enables Immuneerings drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.

Additional info from NASDAQ:
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The companys proprietary computational Disease Cancelling Technology platform enables Immuneerings drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.

2026-08-05 11:30

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

Read more
2026-07-21 20:05

Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition

Read more
2026-07-17 20:29

Gengos Andrew 🟢 acquired 650.0K shares (1 derivative) of Immuneering Corp (IMRX) at $4.78 ($3.1M) Transaction Date: Jul 16, 2026 | Filing ID: 000082

Read more
2026-07-17 20:05

Immuneering Corporation Announces Grants of Inducement Awards

Read more
2026-07-16 17:11

New Form 3 - Immuneering Corp <b>Filed:</b> 2026-07-16 <b>AccNo:</b> 0001790340-26-000080 <b>Size:</b> 11 KB

Read more
2026-06-24 20:11

Director Zeskind Benjamin J. 🟢 acquired 2.4K shares of Immuneering Corp (IMRX) at $4.56 Transaction Date: Jun 23, 2026 | Filing ID: 000078

Read more
2026-06-16 20:15

Hall Brett Matthew 🟢 acquired 6.0K shares of Immuneering Corp (IMRX) at $4.15 Transaction Date: Jun 15, 2026 | Filing ID: 000076

Read more
2026-06-15 20:12

(99% Neutral) IMMUNEERING CORP (IMRX) Announces New Board Appointment

Read more
2026-06-15 11:30

Immuneering Appoints Andrew Gengos as Chief Financial Officer

Read more
2026-06-11 21:37

Director Schall Thomas J. 🟢 acquired 33.4K shares (1 derivative) of Immuneering Corp (IMRX) at $4.12 Transaction Date: Jun 11, 2026 | Filing ID: 000072

Read more